The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.
about
Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.Comparison of m-mode echocardiographic left ventricular mass measured using digital and strip chart readings: the Atherosclerosis Risk in Communities (ARIC) study.Non-dipper treated hypertensive patients do not have increased cardiac structural alterationsLabor Unions: A Public Health InstitutionLeft Ventricular Systolic Function Changes in Primary Hypertension Patients Detected by the Strain of Different Myocardium LayersAssociation of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney diseaseLeft ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.Echocardiographic differentiation of pathological and physiological left ventricular hypertrophyCut off values of waist circumference and associated cardiovascular risk in Egyptians.Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive NigeriansLeft ventricular mass estimation by echocardiography: is it clinically useful?Role of ACE inhibitors in hypertension with left ventricular hypertrophy.Negative stress echocardiographic responses in normotensive and hypertensive patients with angina pectoris, positive exercise stress testing, and normal coronary arteriogramsLeft ventricular hypertrophy.Cognitive functions and cognitive reserve in relation to blood pressure components in a population-based cohort aged 53 to 94 years.Left ventricular mass formulae and prevalence rates of echocardiographic left ventricular hypertrophy in nigerians with essential hypertension.Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study).The influence of the left ventricular geometry on the left atrial size and left ventricular filling pressure in hypertensive patients, as assessed by echocardiography.CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy.Validity of electrocardiographic criteria for increased left ventricular mass in young patients in the general population.Quantitative left ventricular contractility analysis under stress: a new practical approach in follow-up of hypertensive patients.Target organ damage in hypertensive patients: correlation between retinal arteriovenular ratio and left ventricular geometric patterns.Blood pressure variability and its implications for antihypertensive therapy.Hypertension: are beta-blockers and diuretics appropriate first-line therapies?Left ventricular hypertrophy in hypertension--general and local trends in diagnosis and therapy.Left Ventricular Mass as a Risk Factor in the Oldest Old.Racial differences and hypertension.The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.High prevalence of left ventricular hypertrophy in octogenarian women: The Jerusalem Longitudinal Cohort Study.Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients.Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinography.Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria.Left ventricular hypertrophy. Significance in cardiac morbidity and mortality.Serum uric acid level is associated with cardiac hypertrophy in renal transplant recipients.LV mass index significantly impacts on patient and renal outcomes in patients with coronary artery bypass grafting and poor left-ventricular function.Cardiac Remodeling Patterns in Severe Obesity According to Arterial Hypertension Grade.Early cardiac abnormalities and increased C-reactive protein levels in a cohort of children with sleep disordered breathing.Left ventricular longitudinal rotation changes in primary hypertension patients with normal left ventricular ejection fraction detected by two-dimensional speckle tracking imaging.
P2860
Q24799134-0F1B7538-9683-4E29-A061-EE7E3D248F1CQ24800915-13C01298-C6C0-43F1-9600-828B5B7752F0Q24806872-3487B421-65FF-4AE7-A67C-F0E4A5D210B8Q29248347-180852A1-D084-4685-8FC6-5E5AE6D0EBEFQ30391699-966E4DAA-1985-4F19-91C8-AFEF9E283C2BQ30422680-45348C74-4E15-47C4-A5B2-D9B788AFBAC8Q30440409-D32C298B-07FF-43B5-8178-301D74D2E97FQ30542196-3E684DAB-2E57-48E5-B42C-71368154BF63Q31029580-D0873FF4-CC36-4DD1-BFC0-B42072C2CF61Q33255712-4AB75D13-D5E5-42D3-948D-33873645FAB1Q33565998-D05C9A1F-FD1B-4FBB-80A0-AF1A3FA2B82EQ33614275-1CDB6F88-A553-435C-8731-606431BE500AQ35375028-B98DEFAB-9EE1-427A-AC8D-CD56C652768EQ35861560-68D67A2A-B822-4726-92EA-F2D35333F05BQ35884843-E2E66CAE-1835-46F3-B1C3-967492318CBAQ36950084-DC2835DB-DF64-47C8-9D3B-F49AC2306415Q36974119-6C8108BA-7821-4518-86F4-D3BCDD8FDA9AQ37408714-9DF4BAE4-E446-4503-97AC-5DDB20B8E62CQ37634312-05FAC6B8-AE1C-4321-9343-9B8E98DD70DDQ37724055-5B7C383C-6314-49CF-BD53-FEEC258B5CC5Q37812268-9AD6B291-4684-4D48-9CD0-58285B25ED61Q40128033-4586A816-7FB1-49D9-8B6F-12233BD68B25Q40516423-78814987-4F5D-4926-8FED-1EFCDD3109CDQ40625200-6908BEF4-21A0-4B6C-94EA-E0AE1001DCDFQ41036688-D5EC7179-DF1D-41E6-92C3-BC360020C6BEQ41668634-289A8257-182D-4019-9816-98ECD4EB6236Q42584613-447EF7FE-3D21-4269-A662-5D76C62AF79CQ43661160-E5EE23B9-A7CB-4BE3-AE8D-16D5EB6959CCQ44008023-BA305CDD-F9EE-4C41-A5F2-5E66979CED3FQ44087708-53C9DE2A-9775-475F-90CF-FF0C9611B1FDQ44354158-67C889E2-42D2-4DB0-8683-218F6155D814Q44804350-71633AB1-E535-4CB7-AA33-0987C1076719Q44844094-D097B0AE-A747-4478-983F-913FC626A979Q44956531-9A943A6C-C1B6-409E-9CBE-98638F093304Q45288376-D0786104-98FC-413D-8A2B-17A6ECA846E6Q47859472-D9AB7870-4E00-4130-A10A-2EF0D265C572Q47923273-1DE6994C-FA68-49FA-93DF-C6647BF55F9EQ48147930-2EA8CC34-271D-4CFD-AC69-FAA63E06004FQ48323175-8C188DF8-F2CB-4F5C-8E11-AB73B1A0186BQ48674832-69414F46-7160-4501-A005-28A636146FA4
P2860
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
The prevalence and correlates ...... th uncomplicated hypertension.
@en
The prevalence and correlates ...... th uncomplicated hypertension.
@nl
type
label
The prevalence and correlates ...... th uncomplicated hypertension.
@en
The prevalence and correlates ...... th uncomplicated hypertension.
@nl
prefLabel
The prevalence and correlates ...... th uncomplicated hypertension.
@en
The prevalence and correlates ...... th uncomplicated hypertension.
@nl
P2093
P921
P1476
The prevalence and correlates ...... th uncomplicated hypertension.
@en
P2093
I W Hammond
J H Laragh
J S Crowley
M C Spitzer
M H Alderman
R B Devereux
P304
P356
10.1016/S0735-1097(86)80476-4
P407
P577
1986-03-01T00:00:00Z